Results 131 to 140 of about 180,202 (208)

GA treatment does not alter Shiga toxin recycling.

, 2015
HEp-2 cells were preincubated with 10 μM GA for 30 min at 37°C and subsequently incubated with 40 ng/ml biotinylated Shiga toxin 1 mutant for 30 min. Signals from cell surface-associated Shiga toxin were removed and the toxin chased for another 30 min in
Ieva Ailte Hjelseth (745961), Roger Simm (164068), Maria Lyngaas Torgersen (745962), Anne Berit Dyve Lingelem (745960), Kirsten Sandvig (153014)   +4 more
core   +1 more source

Prevalence, Antimicrobial Susceptibility, and Hygienic Practices of Escherichia coli O157:H7 in Raw Meat, Bahir Dar City, Ethiopia

Veterinary Medicine and Science, Volume 12, Issue 5, September 2026.
Escherichia coli O157:H7 was detected in 28.4% of raw meat samples from Bahir Dar City, with 47.6% of isolates carrying at least one stx1 or eaeA virulence gene. Poor hygiene practices and antimicrobial resistance highlight the need for strengthened meat safety surveillance and intervention. ABSTRACT Introduction Escherichia coli O157: H7 is a globally
Wogayehu Asefa, Habtamu Tassew, Tiliksew Bialfew, Esayas Gelaye, Bizuneh Tsehayneh Azene   +4 more
wiley   +1 more source

Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7

, 2016
Si-Ying Wu,1 Gil-Yong Park,1 So-Hee Kim,2 John Hulme,1 Seong Soo A An1 1Department of BioNano Technology, Gachon BioNano Research Institute, Gachon University, Seongnam-si, 2Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea
Kim SH, An SSA, Wu SY, Park GY, Hulme J
core  

Prevalence and Genomic Characterization of mcr‐Positive Enterobacteriaceae in Retail Meat in Thailand Following the Colistin Ban

Microbiology and Immunology, Volume 70, Issue 9, Page 402-415, September 2026.
ABSTRACT This study aimed to investigate the prevalence and characteristics of mcr‐positive Enterobacteriaceae in retail meat in Thailand following the national ban on prophylactic colistin use in food producing animals. A total of 152 meat samples (103 chicken and 49 pork) were collected from supermarkets and open markets between July and September ...
Ahmed Abououf, Sharda Prasad Awasthi, Asmaa M. Elbastawesy, Noritoshi Hatanaka, Atsushi Hinenoya, Srinuan Somroop, Yukihiro Kaneko, Shinji Yamasaki   +7 more
wiley   +1 more source

A Risk‐Based Framework for Ranking Microbiological Hazards and Identifying Mitigation Strategies for Dried Fruits, Vegetables, Herbs, and Spices Used in Ready‐to‐Eat Foods

Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 5, September 2026.
ABSTRACT Low water activity ingredients, including dried fruits, vegetables, herbs, and spices, are widely used in ready‐to‐eat (RTE) and non‐RTE foods. Although low water activity limits microbial growth, bacterial pathogens can survive for extended periods in these products.
Heidy M. W. den Besten, Linda J. Harris, Jennifer C. Acuff, Francois Bourdichon, Rob Limburn, Andreja Rajkovic, Anett Winkler, Polly D. Courtney   +7 more
wiley   +1 more source

Pathogenic Foodborne Bacteria in the Game Meat of Hunted Large Ungulates—A Systematic Review and Meta‐Analysis

Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 5, September 2026.
ABSTRACT Zoonotic bacterial pathogens are a major concern for food safety, yet information regarding their occurrence in game meat remains fragmented. This systematic review synthesizes available data on Salmonella spp., Shiga toxin‐producing Escherichia coli (STEC), Listeria spp., Yersinia spp., and Campylobacter spp.
Maria Fredriksson‐Ahomaa, Silvia Bonardi, Bozena Futoma‐Koloch, Ioannis Sakaridis, Jelena Petrovic, Inge Van Damme   +5 more
wiley   +1 more source

Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non‐Small Cell Lung Cancer

Cancer Science, Volume 117, Issue 9, Page 2535-2542, September 2026.
The flow of this trial and the treatment schedule of adjuvant chemotherapy with nedaplatin plus docetaxel for completely resected non‐small cell lung cancer (NSCLC) (A). The primary endpoint of this study was tolerability, assessed by the completion rate of the planned four chemotherapy cycles. As a result, it was 74.3%, exceeding that reported for the
Koji Teramoto, Ryosuke Kaku, Tomoyuki Igarashi, Masayuki Hashimoto, Shoji Kitamura, Makoto Motoishi, Yuji Suzumura, Satoru Sawai, Yataro Daigo, Jun Hanaoka   +9 more
wiley   +1 more source

An ALKBH3 Inhibitor HUHS199 Suppresses Proliferation of Glioblastoma Cells by Targeting 1‐Methyladenosine on GADD45A mRNA

Chemical Biology &Drug Design, Volume 108, Issue 3, September 2026.
HUHS199, a novel inhibitor of ALKBH3, suppresses glioblastoma cell proliferation, induces G1 cell cycle arrest, and increases RNA m1A levels, with concomitant changes in GADD45A mRNA methylation status, highlighting the pathological relevance of ALKBH3‐mediated RNA demethylation in glioblastoma.
Manami Yamada, Hiroaki Hase, Honoka Kitamura, Toshiya Morie, Shuntaro Aoi, Yuko Ueda, Kaori Kitae, Tatsuhiko Furukawa, Nayuta Higa, Ryosuke Hanaya, Kazutake Tsujikawa   +10 more
wiley   +1 more source

Functional Specialization of Clathrin‐Independent Endocytic Routes: Mechanisms and Cellular Roles

Traffic, Volume 27, Issue 3, September 2026.
Distinct clathrin‐independent endocytic (CIE) routes support specialized cellular functions across different contexts. Created with Biorender.com. ABSTRACT Clathrin‐independent endocytosis (CIE) comprises a diverse repertoire of internalization mechanisms that operate in parallel with clathrin‐mediated endocytosis.
Andrea Francesco Benvenuto, Amir Fardin, Matteo Balestra, Pier Paolo Di Fiore, Chiara Tordonato, Sara Sigismund   +5 more
wiley   +1 more source

Identification of Novel Therapeutic Agent Candidates Through High Throughput Screening With Chemical Library Based on Molecular Subclassification in Canine Histiocytic Sarcoma Cell Lines

Veterinary and Comparative Oncology, Volume 24, Issue 3, Page 554-567, September 2026.
ABSTRACT Effective chemotherapy for canine histiocytic sarcoma (CHS) has yet to be established. In our previous study, CHS cell lines were subclassified into two groups based on their gene expression profiles: Group A and Group B. This study aimed to identify novel therapeutic agents that are effective against each CHS subgroup, and we performed high ...
Hiroki Sakuma, Hirotaka Tomiyasu, Mari Takamiya, Yuko Goto‐Koshino, Atsushi Tsukamoto, Makoto Bonkobara, Masaru Okuda   +6 more
wiley   +1 more source